INTRODUCTION
The intestinal mucosa must rapidly recognise detrimental pathogenic threats to the lumen to initiate controlled immune responses but maintain hyporesponsiveness to harmless lumenal commensals and food antigens. Exaggerated inflammatory responses in the absence of pathogenic bacteria would be otherwise deleterious. If the balance shifts from tolerogenic to immunogenic responses, several inflammatory and autoimmune disorders may be developed, such as coeliac disease, inflammatory bowel disease and necrotizing enterocolitis.
Charles Janeway Jr first suggested that so-called pattern recognition receptors (PRRs) may play an essential role in allowing innate immune cells to discriminate between "self" and microbial "non-self" based on the recognition of broadly conserved molecular patterns (PAMPs). CD14, which is a membrane-associated glycosylphosphatidylinositol-linked protein, was the first described PRR. Toll-like receptors (TLRs) comprise a class of transmembrane PRRs, while nucleotide-binding oligomerization domains (NOD1 and NOD2) are a structurally distinct family of intracellular PRRs.
Intestinal epithelial tolerance versus intolerance towards lumenal bacterial ligands are distinctly mediated through TLRs and NOD2. Recognition of PAMPs by these receptors initiates a signaling pathway, which leads to activation of several adaptor proteins and transcription factors and finally production of proinflammatory cytokines-, chemokines-, type I interferons-and antibacterial peptides, as well as induction of angiogenesis and apoptosis.
In health, TLR signalling protects the intestinal epithelial barrier and confers commensal tolerance whereas NOD2 signalling exerts antimicrobial activity and prevents pathogenic invasion. Aberrant TLR and/or NOD2 signalling induce tissue damage and barrier destruction through exagerrated cytokine and chemokine production and by loss of commensal mediated colonic epithelial progenitor responses, leading to acute and chronic intestinal inflammation with many different clinical phenotypes.
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AIMS
We investigated the expression of Toll-like receptor (TLR) 2, TLR3 and TLR4 in the duodenal mucosa of children with coeliac disease, as well as in the colonic mucosa of children with inflammatory bowel disease. Moreover, we also investigated the association of genetic polymorphisms of CD14, TLR4 and caspase recruitment domain (CARD) 15 with necrotizing enterocolitis (NEC) in very low birth weight infants. Our most important questions were as follows: had been referred with rectal bleeding or obstipation. No significant age-or sex-related differences were observed among children with fdIBD, children with rIBD and controls.
Association of genetic polymorphisms of CD14, TLR4 and CARD15 and necrotizing enterocolitis in very low birth weight infants
We reviewed the records of 118 very low birth weight ( 
Semiquantitative and real-time reverse transcription-polymerase chain reaction (RT-PCR)
RNA isolation and reverse transcription
Total RNA was isolated from the colonic biopsy samples by RNeasy
Total RNA Isolations Kit (Qiagen). The quality and quantity of the RNA were photometrically confirmed. One microgram of total RNA was reverse-transcripted to generate first-strand complementary DNA (cDNA). 
Semiquantitative PCR (human GAPDH, TLR2, TLR3, TLR4)
PCRs were performed with specific primer pairs for TLR2, TLR3 and TLR4 in a total volume of 50 μl. To test the cDNAs (for representation and full length genes) RT-PCR with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed. PCR products were separated by electrophoresis on agarose gels and visualised by staining ethidium bromide under UV illumination. The mRNA expression of each gene was determined by computerized densitometry using Gel-Pro Analyzer version 3.1. The integrated optical density of each PCR product was normalized to that of GAPDH for the same biopsy sample.
SYBR Green real-time PCR (human TLR2, TLR3, TLR4)
The TLR PCRs were performed in glass capillaries, in a final volume of 20 μl containing 1μl cDNA on a Light Cycler system. Specific primer pairs for TLR2, TLR3
and TLR4 were equivalent to those, which were used for the semiquantitative PCR. After each Light Cycler run, PCR products were separated by electrophoresis on agarose gels and visualized by staining with ethidium bromide Results were analyzed by using Light-Cycler software version 3.5.3.
Real-time PCR-fluorescence resonance energy transfer (FRET) (humán GAPDH)
The GAPDH PCR was performed in glass capillaries, in a final volume of 20 μl containing 1μl cDNA on a Light Cycler system. Probes were labelled with the Light
Cycler Red 640 fluorophore and fluorescein. After each Light Cycler run, PCR products were separated by electrophoresis on agarose gels and visualized by staining with ethidium bromide. Results were analyzed by using Light-Cycler software version 3.5.3.
Western blot
Colonic and duodenal biopsy specimens were homogenized in chilled extraction buffer and then the homogenate was centrifuged at 10000 g for 10 min at 4ºC to pellet The values were normalized to an internal standard and expressed as the relative optical density.
PCR-restriction fragment length polymorphism (PCR-RFLP)
DNS isolation
Blood spots were taken on the fifth postnatal day for metabolic screening or after the introduction of oral feeding and then were stored at the Metabolic Screening
Program. We used remnant dried blood samples for genotyping. DNA was extracted from filter papers with an extracting agent (Chelex-100) according to the manufacturer's instructions.
Detection of CD14 C -260 T, TLR4 A +896 G and C +1196 T, as well as CARD15 G +2722 C, C +2104 T and CARD15 3020insC SNPs with PCR-RFLP
PCR amplifications were performed in a total volume of 50 µl containing 2 µl DNA. PCR products were restricted by 10 units of the following restriction enzymes:
and ApaI (CARD15 3020insC). The restricted PCR products were separated on agarose gels and visualized under UV illumination, stained with ethidium bromide. 8
Statistical analysis
After testing the normality with Shapiro-Wilk's test, non parametric MannWhitney U-test was used to determine the levels of difference among all groups for TLR2, TLR3 and TLR4 mRNA expression and protein levels in the duodenal and colonic biopsy samples.
Hardy-Weinberg equilibrium of genotypes and linkage disequilibrium of the tested SNPs were tested using Arlequin software. Allelic and genotype frequencies in VLBW (with and without NEC) and healthy term infants were compared by chi-square test; continuous variables were compared by Mann-Whitney U test. Logistic regression analysis was used for the evaluation of independent effects of clinical characteristics and investigated SNPs on risk and severity of NEC. P values less than or equal to 0.05 were considered statistically significant.
RESULTS
Investigation of TLR2, TLR3 and TLR4 expression in the duodenal mucosa of children with coeliac disease
TLR2, TLR3 and TLR4 mRNA expression
TLR2 and TLR4 mRNA expression were significantly increased in the duodenal mucosa of children with untreated CD and treated CD compared to controls.
We found even higher TLR2 and TLR4 mRNA levels in the duodenal mucosa of children with treated CD than in untreated CD. TLR3 mRNA expression was significantly increased in the duodenal mucosa of children with treated CD, but remained unchanged in the duodenal mucosa of children with untreated CD.
TLR2, TLR3 and TLR4 protein levels
TLR2 protein levels were 2 times higher in the duodenal mucosa of children with untreated CD than in controls. We found even 4 times higher TLR2 protein levels in the duodenal mucosa of children with treated CD than in untreated CD. We were able to detect TLR3 protein only in the biopsy specimens of treated CD patients. We found 3-fold elevation of the TLR4 protein levels in the duodenal mucosa of children with untreated CD in comparison to controls. TLR4 protein levels were 3 times higher in the duodenal mucosa of children with treated CD than in untreated CD.
Investigation of TLR2, TLR3 and TLR4 expression in the colonic mucosa of children with inflammatory bowel disease
TLR2, TLR3 and TLR4 mRNA expression
As we found no difference in the mRNA expression of TLR2, TLR3 and TLR4
in the colonic mucosa of children with Crohn's disease or ulcerative colitis, reported findings were not specified for these subgroups. TLR2 and TLR4 mRNA expression were significantly increased in the inflamed colonic mucosa of children with fdIBD and rIBD compared to controls. In the non-inflamed mucosa of children with fdIBD and rIBD, TLR2 and TLR4 mRNA expression were similar to controls. TLR2 and TLR4
mRNA expression also did not differ between children with fdIBD or rIBD in either inflamed or non-inflamed colonic mucosa. TLR3 mRNA expression remained unchanged in all groups studied.
TLR2, TLR3 and TLR4 protein levels
We observed also no difference in the protein levels of TLR2, TLR3 and TLR4
in the colonic mucosa of children with Crohn's disease or ulcerative colitis, therefore reported findings were not specified for these subgroups. TLR2 protein levels in the inflamed colonic mucosa of children with fdIBD and rIBD were about 9 times higher than in controls. We found about 5-fold elevation of the TLR4 protein levels in the inflamed colonic mucosa of children with fdIBD and rIBD compaired to controls. In the non-inflamed mucosa of children with fdIBD and rIBD, TLR2 and TLR4 protein levels were similar to controls. TLR2 and TLR4 protein levels in either inflamed and noninflamed mucosa were similar in children with fdIBD and rIBD. TLR3 protein levels did not changed significantly in the investigated groups. were observed. These data suggest that in the background of Th1 shift in C and Th2 shift in UC is not the discrepant TLR2, TLR3 or TLR4 mucosal expression.
Association of genetic polymorphisms of CD14, TLR4 and CARD15 and necrotizing enterocolitis in very low birth weight infants
9. We firstly investigated the association of CD14 C -260 T-, as well as TLR4 A +896 G and C +1196 T SNPs with the risk and severity of NEC in very low birth weight (VLBW)
infants. Only one study tested the significance of CARD15 G +2722 C, C +2104 T, as well as 3020insC SNPs in NEC and our findings confirm their results.
10.
We observed that the prevalence of CD14 C -260 T, TLR4 A +896 G and C +1196 T, as well as CARD15 G +2722 C, C +2104 T and 3020insC SNPs did not differ between VLBW infants with or without NEC. Furthermore, these SNPs were not associated with the stage of NEC. We could not demonstrate any association between other perinatal complications or risk factors (patent ductus arteriosus, bronchopulmonary dysplasia or intracranial hemorrhage) and the investigated SNPs.
11.
Our results suggest that the carrier state of the tested CD14, TLR4 and CARD15
SNPs is not associated with NEC risk in VLBW infants. Further investigation with larger cohorts of VLBW subjects with NEC would be helpful to better define the role of these SNPs in perinatal pathology. 
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